Results of EAHP's 2019 Medicines Shortages Survey.
Drug Costs
Drug Industry
/ statistics & numerical data
Europe
Health Personnel
/ statistics & numerical data
Humans
Patient Care
/ standards
Pharmaceutical Preparations
/ economics
Pharmacists
/ statistics & numerical data
Pharmacy Service, Hospital
/ statistics & numerical data
Surveys and Questionnaires
drug manufacturing / preparation / compounding
drug procurement
health & safety
health policy
pharmacy management (organisation, financial)
Journal
European journal of hospital pharmacy : science and practice
ISSN: 2047-9956
Titre abrégé: Eur J Hosp Pharm
Pays: England
ID NLM: 101578294
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
30
04
2020
revised:
05
05
2020
accepted:
12
05
2020
pubmed:
31
5
2020
medline:
3
7
2021
entrez:
31
5
2020
Statut:
ppublish
Résumé
The aim of the 2019 EAHP Medicines Shortages Survey was to collect information on reasons and management strategies for medicines shortages as well as details on their impact on patients. The survey targeted hospital pharmacists (HPs), physicians (PHYs), nurses (NRS) and other healthcare professionals (OHCPs). A separate set of questions addressed patients (PTNs). A 28-question survey was conducted by EAHP, collecting information from European HPs, PTNs, NRS, PHYs and OHCPs on the shortage situation in their respective countries. The survey ran from 7 November 2019 to 13 January 2020. The results were analysed by EAHP. There were 2136 HP responses to the 2019 survey compared with 1666 in 2018. While 95% of HPs and 89% of OHCPs consider medicine shortages a current problem, only 71% of PHYs and 62% of NRS state the same. Shortages of active pharmaceutical ingredients (72%), manufacturing (72%) and supply chain problems (49%) are leading causes of shortages according to HPs, while PHYs (40%) and NRS (37%) consider the pricing to be their driver. Antimicrobials and oncology medicines were most affected by shortages in 2019. Compared to 2018, the percentage of respondents who reported shortages of oncology medicines increased from 39% to 47% in 2019. HPs (42%), PHYs (36%) and OHCPs (38%) consider delays in care as the main consequence of medication shortages. The satisfaction with reporting systems for medicine shortages decreased from 56% in 2018 to 48% in 2019 for HPs, while they remain low for PHYs (36%). Medicines shortages affect patient care and healthcare professionals' everyday tasks. Better enforcing of the mandatory early notification of shortages and structured mitigation response is recognised by all respondents as best strategy to tackle shortages.
Identifiants
pubmed: 32471816
pii: ejhpharm-2020-002341
doi: 10.1136/ejhpharm-2020-002341
pmc: PMC7335625
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
202-208Informations de copyright
© European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Infect Dis. 2017 Aug 15;65(4):613-618
pubmed: 28444166
Hosp Pharm. 2015 Apr;50(4):279-86
pubmed: 26448658
Am J Health Syst Pharm. 2018 Nov 1;75(21):1742-1750
pubmed: 30061155
Eur J Hosp Pharm. 2019 Mar;26(2):60-65
pubmed: 31157101
PLoS One. 2017 Mar 28;12(3):e0174556
pubmed: 28350827
Pharmacotherapy. 2012 Aug;32(8):665-7
pubmed: 22744833
Infect Control Hosp Epidemiol. 2012 Jul;33(7):745-52
pubmed: 22669238
Am J Health Syst Pharm. 2011 Oct 1;68(19):1811-9
pubmed: 21930639
Front Pharmacol. 2019 Jul 19;10:763
pubmed: 31379565
PLoS One. 2019 May 3;14(5):e0215837
pubmed: 31050671
Mayo Clin Proc. 2014 Mar;89(3):361-73
pubmed: 24582195
Front Pharmacol. 2018 Jan 18;8:942
pubmed: 29403372
Open Forum Infect Dis. 2018 Apr 23;5(4):ofy068
pubmed: 29732380
Front Pharmacol. 2020 Mar 26;11:357
pubmed: 32273845